Dissecting origin factors of lymph node metastasis in non-small cell lung cancer via multimodal omics.
Scientists have mapped how lung cancer spreads to lymph nodes, revealing potential weaknesses that targeted therapies might exploit.
Integrating genomic, transcriptomic, and proteomic data from NSCLC samples, this study identifies molecular mechanisms and origin factors underlying lymph node metastasis, the critical step preceding distant spread. The findings map therapeutic vulnerabilities and prognostic markers relevant to precision oncology approaches in NSCLC.
What the study was
- Study design
- Multimodal genomic/transcriptomic/proteomic profiling study
- Population
- Non-small cell lung cancer patients with lymph node metastasis
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Nature communications
Why it surfaced
Nat Commun multimodal omics study of NSCLC LN metastasis origin; high scientific quality, actionable targets, but exploratory evidence maturity.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.